Literature DB >> 8206401

Technically accurate intracavitary insertions improve pelvic control and survival among patients with locally advanced carcinoma of the uterine cervix.

B W Corn1, A L Hanlon, T F Pajak, J Owen, G E Hanks.   

Abstract

The purpose of this study was to document whether the technical qualities of a brachytherapy application impacts on the outcome of patients with locally advanced cervix cancer treated by definitive irradiation. A previous report from the patterns of care study demonstrated the importance of brachytherapy in the treatment of locally advanced cervix cancer. Locally advanced disease was defined as FIGO stages Ib (if tumor diameter was < or = 4 cm), IIb (if disease was bilateral or involved the lateral aspect of either parametrium), and III. Localization films from 128 patients with locally advanced squamous cell carcinoma of the cervix were reviewed by a radiation physicist and a radiation oncologist with expertise in gynecologic radiotherapy. All patients received external beam irradiation followed by one brachytherapy application (median point A dose = 8040 cGy; range, 4083-10,020 cGy). Brachytherapy parameters assessed were (a) the distance between the right colpostat source and the distal tandem source, (b) the distance between the left colpostat source and the distal tandem source, and (c) the symmetry of colpostat placement. Implants were scored as "ideal" (n = 8) when all three parameters were deemed satisfactory, "unacceptable" (n = 17) when none of the parameters was deemed satisfactory, and "adequate" (n = 41) in all other cases. Significantly improved 5-year local control was seen when comparing ideal and adequate placements to unacceptable placements (68% vs 34%, P = 0.02). A strong trend toward improved 5-year survival was also noted among the group with ideal and adequate implants as opposed to unacceptable implants (60% vs 40%). Multivariate analysis showed that the technical adequacy of the brachytherapy implant was the most important prognostic discriminant of local control. In conclusion, these analyses demonstrate the direct influence of competent technical implant performance on tumor control and even survival. While only a small fraction of implants for cervical cancer are performed poorly in the United States, there is a need for continued emphasis of the principles for proper implant technique.

Entities:  

Mesh:

Year:  1994        PMID: 8206401     DOI: 10.1006/gyno.1994.1137

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  20 in total

Review 1.  Brachytherapy in Gynecologic Cancers: Why Is It Underused?

Authors:  Kathy Han; Akila N Viswanathan
Journal:  Curr Oncol Rep       Date:  2016-04       Impact factor: 5.075

Review 2.  Imaging-guided brachytherapy for locally advanced cervical cancer: the main process and common techniques.

Authors:  Zhongshan Liu; Yangzhi Zhao; Yunfeng Li; Jing Sun; Xia Lin; Tiejun Wang; Jie Guo
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

3.  The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128.

Authors:  Akila N Viswanathan; Jennifer Moughan; William Small; Charles Levenback; Revathy Iyer; Sharon Hymes; Adam P Dicker; Brigitte Miller; Beth Erickson; David K Gaffney
Journal:  Int J Gynecol Cancer       Date:  2012-01       Impact factor: 3.437

4.  Uterine perforation - 5-year experience in 3-D image guided gynaecological brachytherapy at Institute of Oncology Ljubljana.

Authors:  Barbara Segedin; Jasenka Gugic; Primoz Petric
Journal:  Radiol Oncol       Date:  2013-05-21       Impact factor: 2.991

5.  Uterine perforation and its dosimetric implications in cervical cancer high-dose-rate brachytherapy.

Authors:  Yasir A Bahadur; Maha M Eltaher; Ashraf H Hassouna; Mohammad A Attar; Camelia Constantinescu
Journal:  J Contemp Brachytherapy       Date:  2015-02-04

Review 6.  Brachytherapy in the treatment of cervical cancer: a review.

Authors:  Robyn Banerjee; Mitchell Kamrava
Journal:  Int J Womens Health       Date:  2014-05-28

7.  Patterns of care study of brachytherapy in New South Wales: cervical cancer treatment quality depends on caseload.

Authors:  Stephen R Thompson; Geoff P Delaney; Gabriel S Gabriel; Michael B Barton
Journal:  J Contemp Brachytherapy       Date:  2014-04-03

8.  Acute complications following intracavitary high-dose-rate brachytherapy in uterine cancer.

Authors:  Phalguni Gupta; Ranen Kanti Aich; Asit Ranjan Deb
Journal:  J Contemp Brachytherapy       Date:  2014-09-23

9.  Optimal therapy for IB2 and IIA2 cervical cancer: surgery or chemoradiotherapy?

Authors:  David K Gaffney
Journal:  J Gynecol Oncol       Date:  2012-09-19       Impact factor: 4.401

10.  Impact of point A asymmetry on local control and survival for low dose-rate (LDR) brachytherapy in cervical cancer.

Authors:  Krisha J Opfermann; Amy Wahlquist; John Watkins; Matthew Kohler; Joseph Jenrette
Journal:  J Contemp Brachytherapy       Date:  2012-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.